Indian stocks: Visit www.stage2stocks.com →

AdaptHealth Corp.

Stage 4 · Declining · week 14

As of Oct 22, 2026, AdaptHealth is in Stage 4, the downtrend phase, now in week 14 (since Jul 20, 2026). It closed at $6.17, 53.9% below its 52-week high and below its 200-day average, which is falling.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. More about the company

$6.17
+1.15% today
$823M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is AHCO early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 24w
S2 14w
S4 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 5w → S4 24w → S1 5w → S2 7w → S3 5w → S2 8w → S3 2w → S2 4w → S3 2w → S2 2w → S3 2w → S4 9w → S1 2w → S4 3w → S1 4w → S4 13w → S1 12w → S4 7w → S1 1w → S2 14w → S3 3w → S2 10w → S3 5w → S4 14w current
Total tracked: 165 weeks across 24 stage runs.

AHCO among Medical Devices77th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…77AHCOStage 4 · wk 1430+8.2%
vs 52W High
-53.9%
$5.22 lo$13.38 hi
53.9% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 14
1w13w26w
Week 14, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-33.9%
200 DMA: $9.33 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.85x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+8.2%
3M
-42.7%
6M
-51.5%
YTD
-36.2%
1Y
-35.9%
Scan Membership
Breakout Watch
Latest: 2024-10-30
9 appearances in last 60 days. First seen: 2019-03-18.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 14 · Vol 0.85x
2026-10-21S4
Wk 14 · Vol 0.38x
2026-10-20S4
Wk 14 · Vol 0.82x
2026-10-19S4
Wk 13 · Vol 1.23x
2026-10-16S4
Wk 13 · Vol 0.71x
2026-10-15S4
Wk 13 · Vol 0.51x
2026-10-14S4
Wk 13 · Vol 0.53x
2026-10-13S4
Wk 13 · Vol 0.62x
2026-10-12S4
Wk 12 · Vol 0.44x
2026-10-09S4
Wk 12 · Vol 0.42x
2026-10-08S4
Wk 12 · Vol 0.89x
2026-10-07S4
Wk 12 · Vol 0.86x
Moving averages & range
50 DMA
$5.85
200 DMA
$9.33
52W High
$13.38
52W Low
$5.22
5D Low
$5.88
Resistance levels (recent highs)
20d High
$6.39
60d High
$10.83
120d High
$13.04
250d High
$13.38
Next resistance
+3.6%
to 20d High
ROE
-15.2%
Profit margin -6.8%
Dividend Yield
0.00%
P/B 0.6

AdaptHealth: quick answers

What stage is AdaptHealth in?

As of Oct 22, 2026, AdaptHealth (AHCO) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 20, 2026 and is in week 14. What the four stages mean

Is AdaptHealth in an uptrend?

No. AdaptHealth is in a Stage 4 downtrend. It trades 33.9% below its 200-day average, which is falling.

How far is AdaptHealth from its 52-week high?

AdaptHealth closed at $6.17 on Oct 22, 2026, 53.9% below its 52-week high of $13.38. Its 52-week low is $5.22.

How has AdaptHealth performed over the past year?

As of Oct 22, 2026, AdaptHealth is down 35.9% over the past year and down 36.2% so far in 2026.

Which sector and industry is AdaptHealth in?

AdaptHealth is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.